Form 4: Walgreens Boots Alliance Director Valerie Jarrett Reports Acquisition of Phantom Stock Units

Sentiment:

SEC Form 4 Filing


Director Valerie Jarrett reports acquiring phantom stock units in Walgreens Boots Alliance, Inc. as part of non-employee director compensation.

Summary

  • Valerie Jarrett, a director of Walgreens Boots Alliance, Inc., filed a Form 4 on April 18, 2025, reporting a transaction that occurred on April 16, 2025.
  • The transaction involved the acquisition of 2,777.78 phantom stock units at a price of $10.8 per unit.
  • These phantom stock units are issued as non-employee director compensation under the Walgreens Boots Alliance, Inc. Amended and Restated 2021 Omnibus Incentive Plan.
  • Each phantom stock unit is the economic equivalent of one share of the company's common stock and will be settled following termination of service as a director.
  • Following the reported transaction, Jarrett beneficially owns 66,613.76 phantom stock units, including units issued in lieu of dividends.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as it reflects standard director compensation practices and aligns director interests with shareholders.

Positives

  • The acquisition of phantom stock units aligns the director's interests with those of the shareholders.
  • The compensation plan incentivizes directors to contribute to the long-term success of the company.

Future Outlook

The phantom stock units will be settled following termination of service as a director, in accordance with the terms and conditions of the Plan.

Industry Context

Reporting of beneficial ownership changes by company insiders is a standard practice and provides transparency to investors.

Comparison to Industry Standards

  • Director compensation packages often include equity-based awards like phantom stock units to align director interests with shareholder value.
  • Companies like CVS Health and Rite Aid also utilize similar compensation strategies for their board members.
  • The specific amount and terms of the phantom stock units are typical for director compensation within the retail pharmacy industry.

Stakeholder Impact

  • The acquisition of phantom stock units by a director can positively influence shareholder confidence by aligning director interests with company performance.

Key Dates

DateDescription
04/16/2025Date of transaction: Acquisition of phantom stock units.
04/18/2025Date of Form 4 filing.

Keywords

Form 4, Walgreens Boots Alliance, Phantom Stock Units, Director Compensation, Valerie Jarrett, WBA, Beneficial Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.